Funding daily

Mammoth Biosciences reached a Unicorn status following a $150 million investment round

What is Mammoth Biosciences?

Mammoth Biosciences is a CRISPR application.

What does Mammoth Biosciences do?

The company is developing CRISPR applications for disease detection, research, agriculture, biodefense, and more.

Who owns Mammoth Biosciences?

Ashley Tehranchi, Janice Chen, Jennifer Doudna, Lucas Harrington, and Trevor Martin founded the company in 2017 in San Francisco Bay Area.

How much has Mammoth Biosciences raised?

The company announced that it raised $150 million in a Series D financing round, reaching a valuation of more than $1 billion and reaching a Unicorn status.

Who has invested in Mammoth Biosciences?

Plum Alley Investments and Decheng Capital are the most recent investors.

What domain name does Mammoth Biosciences operate on?

Mammoth Biosciences is operating on the domain name.

Related reads

8 Common frustrations when acquiring a domain name for your brand

Stop spending your money on a premium domain name you don’t own

The fastest-growing companies in the World and their domain name choices

Tsani Gramatikova

An extroverted introvert who enjoys reading, cooking and just chilling.

Related Articles

Back to top button